New research may help doctors determine when (and when not) to test for antiglutamate decarboxylase antibodies in patients with neurological disorders and psychiatric symptoms.
Here: the most notable changes in the new AAN guideline on mild cognitive impairment.
The genetics of dementia, dyslipidemia, and diabetes may hold the key to preventive therapy.
Can cardiovascular fitness help older adults ward off dementia?
What effects do illness and treatment have on cognition? Here's a deep dive.
Personal enhancements (eg, cosmetic surgery) have gained societal acceptance, but cognitive enhancement poses significant ethical, philosophical, and sociopolitical issues.
As clinicians, we can daily apply knowledge learned from a few patients with pure amnesia to patients we see often—those who have memory deficits, such as so-called Mild Cognitive Impairment and neurodegenerative diseases, such as Alzheimer's.